This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Feb 3;139(5):642-643.

doi: 10.1182/blood.2021014301.

Getting ALK inhibitors SHPshape

Ryan A Wilcox¹

Affiliations

PMID: 35113153
DOI: 10.1182/blood.2021014301

Free article

Editorial

Getting ALK inhibitors SHPshape

Ryan A Wilcox. Blood. 2022.

Free article

. 2022 Feb 3;139(5):642-643.

doi: 10.1182/blood.2021014301.

Author

Ryan A Wilcox¹

Affiliation

¹ University of Michigan.

PMID: 35113153
DOI: 10.1182/blood.2021014301

No abstract available

PubMed Disclaimer

Comment on

Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.
Karaca Atabay E, Mecca C, Wang Q, Ambrogio C, Mota I, Prokoph N, Mura G, Martinengo C, Patrucco E, Leonardi G, Hossa J, Pich A, Mologni L, Gambacorti-Passerini C, Brugières L, Geoerger B, Turner SD, Voena C, Cheong TC, Chiarle R. Karaca Atabay E, et al. Blood. 2022 Feb 3;139(5):717-731. doi: 10.1182/blood.2020008136. Blood. 2022. PMID: 34657149 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems